BUSINESS
Alembic Pharmaceuticals surges on securing USFDA’s final approval for ‘Dapagliflozin Tablets’
Mumbai, April 7 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 681.40, up by 25.25 points or 3.85 % from its previous closing of Rs. 656.15 on…



